Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UK Expects…The AAR Innovation Review To Be More Than A Few Silver Bullets

This article was originally published in Clinica

Executive Summary

Enthusiasm surrounding the UK’s Accelerated Access Review (AAR), a program to speed innovative drugs, devices, diagnostics and digital products into usage in NHS England, was brought to a crescendo in early September. That was when AAR expert on medtech and external advisory group member John Jeans exhorted full participation in the online consultation on the AAR website.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst